{"entity":{"type":"insider","cik":"0001832553","url":"/insider/0001832553","json_url":"/insider/0001832553.json","name":"Izumi Raquel E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2021-08-06","last":"2023-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Izumi Raquel E.","source":"filing","n_filings":4,"first_seen":"2021-08-06","last_seen":"2023-08-10"}],"transactions":[{"id":8353388,"accession":"0000950170-23-041513","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-041513","line_url":"/filing/0000950170-23-041513#line-2","is_derivative":false,"issuer_cik":"0001796129","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001796129","owner_cik":"0001832553","owner_name":"Izumi Raquel E.","owner_display_name":"Izumi Raquel E.","owner_url":"/insider/0001832553","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3440.0,"shares_display":"3,440","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":3199.2,"total_display":"3,199.20","total_whole":"3,199","shares_owned_after":85214.0,"shares_owned_after_display":"85,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-10","scope":"insider"},{"id":8353384,"accession":"0000950170-23-041513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-041513","line_url":"/filing/0000950170-23-041513#line-1","is_derivative":false,"issuer_cik":"0001796129","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001796129","owner_cik":"0001832553","owner_name":"Izumi Raquel E.","owner_display_name":"Izumi Raquel E.","owner_url":"/insider/0001832553","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13036.0,"shares_display":"13,036","price_per_share":0.9002,"price_display":"0.90","price_state":"stated","total_value":11735.0072,"total_display":"11,735.01","total_whole":"11,735","shares_owned_after":81774.0,"shares_owned_after_display":"81,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-10","scope":"insider"},{"id":6140619,"accession":"0000899243-22-038530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038530","line_url":"/filing/0000899243-22-038530#line-1","is_derivative":false,"issuer_cik":"0001796129","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001796129","owner_cik":"0001832553","owner_name":"Izumi Raquel E.","owner_display_name":"Izumi Raquel E.","owner_url":"/insider/0001832553","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28738.0,"shares_display":"28,738","price_per_share":0.8848,"price_display":"0.88","price_state":"stated","total_value":25427.3824,"total_display":"25,427.38","total_whole":"25,427","shares_owned_after":68738.0,"shares_owned_after_display":"68,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-14","scope":"insider"},{"id":6620467,"accession":"0000899243-22-024507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024507","line_url":"/filing/0000899243-22-024507#line-1","is_derivative":false,"issuer_cik":"0001796129","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001796129","owner_cik":"0001832553","owner_name":"Izumi Raquel E.","owner_display_name":"Izumi Raquel E.","owner_url":"/insider/0001832553","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.4078,"price_display":"1.41","price_state":"stated","total_value":56312.0,"total_display":"56,312.00","total_whole":"56,312","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":5132693,"accession":"0000899243-21-031927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-031927","line_url":"/filing/0000899243-21-031927#line-1","is_derivative":false,"issuer_cik":"0001796129","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001796129","owner_cik":"0001832553","owner_name":"Izumi Raquel E.","owner_display_name":"Izumi Raquel E.","owner_url":"/insider/0001832553","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.96,"price_display":"11.96","price_state":"stated","total_value":11960.0,"total_display":"11,960.00","total_whole":"11,960","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796129","name":"Vincerx Pharma, Inc.","url":"/issuer/0001796129","role":"Director, Officer","n_filings":4,"first_seen":"2021-08-06","last_seen":"2023-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001832553","retrieved_at":"2026-08-26T23:52:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}